JNM CE/SAM (December 2018): Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non–Nuclear Medicine Techniques

MOC Part II SAM Modules

JNM CE/SAM (December 2018): Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non–Nuclear Medicine Techniques

JNM, December 2018, Volume 59, Number 12

Release Date: 12/1/2018 Expiration Date: 12/31/2021

SNMMI Members: Free Non-Members: $69.00

Continuing Education Credit Information

 


AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 2.0 SAMs have been awarded for this activity.



Objectives
On successful completion of this activity, participants should be able to…
1. Describe the mechanisms of actions of the most used ablation techniques.
2. Discuss the potential advantages and disadvantages of each thermal ablation modality.
3. Discuss the differences between current transarterial therapies.
4. Describe the rationale and treatment selection of the appropriate locoregional modality for the specific clinical indications.


Target Audience
This article contains information of value to physicians, residents, and technologists..

Authors
Francois H. Cornelis1,2 and Stephen B. Solomon1

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and 2Sorbonne Universite, Department of Radiology, Tenon Hospital, Paris, France

 

Financial Disclosure    

Name

Role

Disclosure

Francois H. Cornelis

Author

No relevant financial relationships to disclose.

Stephen B. Solomon

Author

He is a Consultant/Advisor for BTG, Johnson & Johnson, Medtronic, XACT, Adgero, an Investigator for GE Healthcare and AngioDynamics, and has Investment Interest with Johnson & Johnson

The JNM editors, reviewers and SNMMI Staff have indicated that they do not have a financial interest, arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content of manuscripts submitted to JNM.

Todd E. Peterson, PhD

Chair, Publications Committee

Johannes Czernin, MD

Editor-In-Chief

Heiko Schoder, MD

Associate Editor, Continuing Education

Arnold M. Strashun, MD

Chair, Continuing Education Committee

Norbert Avril, MD

JNM Reviewer

David Groheux, MD

JNM Reviewer

Susan Alexander

SNMMI Staff, Publications

Caroline Krystek

SNMMI Staff, Education

No Commercial Support was received for this activity.
The authors were supported in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.

In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the planners and authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.  



Contact Information
For questions please contact Lisa Dickinson, Associate Director of Education at ldickinson@snmmi.org or 703-652-6783.

Start Now